Stockscreener 앱 받기
0.4514
15.74%
0.0614
시간 외 거래:
.44
-0.0114
-2.53%
IGC Pharma Inc 주식(IGC)의 최신 뉴스
Published on: 2025-08-27 10:57:32 - Newser
Is now a turning point for IGC Pharma Inc.Weekly Stock Summary & Smart Money Movement Alerts - Newser
IGC Pharma Announces Coverage Report by Ascendiant Capital Markets about the "Reports Q1 results. We believe more positive clinical data and progress in 2025 to be strong catalysts for stock. Raising P/T to $4.50." - ACCESS Newswire
Analyst Sees Strong Catalysts for IGC Pharma in 2025, Raises Price Target Following Q1 Results - Stock Titan
Sector ETF performance correlation with IGC Pharma Inc.2025 Volatility Report & Weekly Chart Analysis and Guides - Newser
IGC Pharma Inc. stock retracement – recovery analysisTrade Risk Report & Weekly Top Gainers Trade List - Newser
Using AI based signals to follow IGC Pharma Inc.2025 Risk Factors & Growth-Oriented Investment Plans - Newser
Long term hold vs stop loss in IGC Pharma Inc.Trade Analysis Report & Weekly Momentum Picks - Newser
How IGC Pharma Inc. stock performs during market volatilityJuly 2025 Drop Watch & Daily Stock Trend Reports - Newser
Leading vs lagging indicators on IGC Pharma Inc. performance2025 Momentum Check & Safe Capital Preservation Plans - Newser
Real time breakdown of IGC Pharma Inc. stock performanceEarnings Overview Report & Expert Approved Momentum Ideas - Newser
Can machine learning forecast IGC Pharma Inc. recoveryWeekly Profit Summary & Risk Managed Investment Entry Signals - Newser
Trend analysis for IGC Pharma Inc. this weekJuly 2025 Price Swings & Verified Entry Point Signals - Newser
What’s the recovery path for long term holders of IGC Pharma Inc.Trade Performance Summary & Fast Exit and Entry Strategy Plans - Newser
Risk vs reward if holding onto IGC Pharma Inc.July 2025 Weekly Recap & Community Consensus Stock Picks - Newser
Is IGC Pharma Inc. stock bottoming out2025 Sector Review & Low Risk High Reward Ideas - Newser
IGC Pharma Expands CALMA Phase 2 Trial with Site at Lynn Health Science Institute in Oklahoma City - ACCESS Newswire
Major Alzheimer's Agitation Treatment Trial Expands: IGC Pharma Adds Oklahoma Research Site - Stock Titan
Key metrics from IGC Pharma Inc.’s quarterly dataJuly 2025 Fed Impact & Low Drawdown Investment Ideas - Newser
Is IGC Pharma Inc. likely to announce a buybackJuly 2025 Trade Ideas & Real-Time Market Sentiment Reports - sundaytimes.kr
IGC Pharma Inc. Added to High Probability Setup ListWeekly Trend Recap & Free Long-Term Investment Growth Plans - newsyoung.net
IGC Pharma Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingQuarterly Profit Summary & Smart Money Movement Alerts - Newser
Can IGC Pharma Inc. recover in the next quarterPortfolio Value Summary & Weekly Momentum Stock Picks - Newser
What hedge funds are buying IGC Pharma Inc.2025 Trading Recap & AI Powered Buy/Sell Recommendations - sundaytimes.kr
Can IGC Pharma Inc. outperform in the next rallyBond Market & Breakout Confirmation Trade Signals - kpenews.com
IGC Pharma Reports Q1 EPS, Revenue Growth, and Advances Clinical Trials for Alzheimer's Treatment - AInvest
How to build a dashboard for IGC Pharma Inc. stock2025 EndofYear Setup & High Conviction Trade Alerts - Newser
Understanding IGC Pharma Inc.’s price movementEarnings Growth Report & Expert-Curated Trade Recommendations - Newser
IGC Pharma Inc. Reaches Critical Trendline SupportJuly 2025 Closing Moves & Consistent Profit Focused Trading Strategies - kangso.co.kr
Published on: 2025-08-19 15:10:24 - Newser
IGC Pharma : Notice & Access 2025 ASM - MarketScreener
IGC Pharma : Letter to Stockholders FYE2025 Annual Report - MarketScreener
Can a trend reversal in IGC Pharma Inc. lead to recoveryPortfolio Update Summary & Reliable Entry Point Trade Alerts - Newser
IGC Pharma Reports Q1 FY2026 Financial Results, Accelerates Phase 2 Alzheimer's Trial - AInvest
IGC Pharma Reports First Quarter Fiscal 2026 Financial Results; Company Accelerates Phase 2 Alzheimer's Trial - Newswire.com
Igc Pharma’s Risky Venture: Navigating Financial Instability Amid Bitcoin Investment Plans - MSN
Volume Profile Shows Strong Base for IGC Pharma Inc.Portfolio Risk Report & Accurate Trade Setup Notifications - kangso.co.kr
0.98%
8.06%
자본화:
|
볼륨(24시간):